Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2010 Jan;119(2):379–390. doi: 10.1007/s10549-009-0575-y

Table 1. PIK3CA Mutation Frequency.

Results from exon 9 and exon 20 mutational screens from the P024, RAD2222 POL and Z1031 trials. For the P024 and RAD2222 trials, total sample numbers are from the cases in which mutation status of both PIK3CA exons were determined. PIK3CA KD and HD mutation status was determined in all POL and Z1031 cases.

PIK3CA Mutations in P024 Cases Domain Exon

G1624A:E542K 8 Helical 9
G1633A:E545K 8 Helical 9
T1568C:L523S 1 Helical 9
G1573A:E525K 1 Helical 9
T1592C:L531P 1 Helical 9
Total in HD (%) 18/152 (11.8%)
A3140G:H1047R 29 Kinase 20
Total in KD (%) 29/163 (17.8%)

Total 45/153 (29.4%)
PIK3CA Mutations in RAD2222 Cases Domain Exon

G1633A:E545K 9 Helical 9
G1624A:E542K 2 Helical 9
C1636A:Q546K 2 Helical 9
A1634G:E545G 1 Helical 9
Total in HD (%) 14/102 (13.7 %)
A3140G:H1047R 19 Kinase 20
A3140T:H1047R 2 Kinase 20
A3127G:M1043V 1 Kinase 20
C3139T:H1047Y 1 Kinase 20
C3145G:G1049R 1 Kinase 20
C3145T:G1049A 1 Kinase 20
3204_3205ins A:NSTOP>KLKRSTOP 1 Kinase 20
Total in KD (%) 26/102 (25.5%)

Total 38/97 (39.2%)
PIK3CA Mutations in POL Cases Domain Exon

G1624A:E542K 2 Helical 9
G1633A:E545K 4 Helical 9
C1370G:N457K 1 C2 7
Total in HD (%) 7/79 (10%)
A3140G:H1047R 13 Kinase 20
A3140T:H1047L 4 Kinase 20
G3068T:R1023L 1 Kinase 20
Total in KD (%) 18/79 (22.8%)

Total 25/79 (31.7%)
PIK3CA Mutations in Z1031 Cases Domain Exon

G1624A:E542K 3 Helical 9
G1633A:E545K 4 Helical 9
Total in HD (%) 7/69 (10.1%)
A3140G:H1047R 12 Kinase 20
Total in KD (%) 12/69 (17.4%)

Total 19/69 (27.5%)